INS and Insulin resistance: Therefore, we speculate on the hypothesis that the methylation at specific sites of the insulin-sensitive genes CTNND2 and LPL may act as biomarkers of whole body insulin resistance, given a possible effect of DNA methylation on gene expression, with subsequent consequences in insulin resistance-related diseases.